
Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. The Iterative Health Site Network is a premier network of 70+ clinical research sites across US and Europe accelerating the path to market for gastrointestinal (GI) and hepatology novel therapies. Our focus is on driving the success and growth of our partner sites by empowering them with tech-enabled services. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need.
About the Role
We are seeking a detail-oriented and commercially driven Manager of Business Development to own end-to-end BD execution across our IBD, broader GI, and hepatology portfolio. This is a highly cross-functional role that sits at the intersection of commercial strategy, site operations, and sponsor partnerships. Reporting to the Director of Business Development, you will serve as the primary internal point of contact for new contracts and play a critical role in ensuring seamless execution from lead to signed study. You will own the processes, metrics, and relationships that keep our BD pipeline moving — and ultimately help bring new therapies to patients faster.
Responsibilities
Required Qualifications
Preferred Qualifications
New York pay range $75,000—$130,000 USD
At Iterative Health, we’re actively working towards creating an environment that is representative of the diversity of patients our technology serves. We are focused on building an equitable and inclusive culture, and by extension, hiring process. If you require any accommodations to make the application process or interviewing experience more accessible to you, please contact CandidateAccommodations@iterative.health.

Iterative Health is a healthcare services company accelerating the advancement of clinical research to improve patient outcomes. Our Site Network includes over 80 premier clinical research sites across the U.S. and Europe, focused on bringing novel therapies in gastroenterology and hepatology to market faster. We partner closely with sites to streamline trial execution and support sustainable growth. With deep expertise in clinical operations and study execution, we help research teams and sponsors expand access to promising new treatments for the patients who need them most.